Polymorphism of DC-SIGN (CD209) promoter in association with clinical symptoms of dengue fever

Viral Immunol. 2014 Jun;27(5):245-9. doi: 10.1089/vim.2013.0119. Epub 2014 May 5.

Abstract

C-type lectin DC-SIGN receptor, encoded by CD209, plays a key role in the infection of dendritic cells by dengue virus (DENV). Because the -336A/G SNP (rs4804803) polymorphism in the promoter of CD209 modulates DC-SIGN expression, we investigated the putative association of this polymorphism with DENV infection and its pathogenesis. A control sample of 72 individuals, rigorously selected through a clinical investigation for absence of past dengue fever (DF) was compared to a sample of 168 patients (156 classical DF; 12 dengue hemorrhagic fever), all residents from Pará, Brazil. However, the prevalence of symptoms showed a trend higher in the AA genotype (Wilcoxon test; Z=2.02; p=0.04). Hence, our findings indicate that the G allele downregulates the spectrum of symptoms during the early acute phase of DENV infection, putatively decreasing the viremia, as suggested in the literature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brazil
  • Case-Control Studies
  • Cell Adhesion Molecules / genetics*
  • Dengue / genetics*
  • Dengue / pathology*
  • Female
  • Humans
  • Lectins, C-Type / genetics*
  • Male
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic*
  • Receptors, Cell Surface / genetics*

Substances

  • Cell Adhesion Molecules
  • DC-specific ICAM-3 grabbing nonintegrin
  • Lectins, C-Type
  • Receptors, Cell Surface